Zhuhai, China

Yongle Chen

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Livzon Pharmaceutical Group Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongle Chen. Retrieved from https://idiyas.com/inventor/yongle-chen-vv0yuhl1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yongle Chen: Innovator in Pharmaceutical Compounds

Introduction

Yongle Chen is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optically pure compounds. His work is essential for advancing medical treatments and improving patient care.

Latest Patents

Yongle Chen holds a patent for "Substituted sulfoxide compounds, methods for preparing the same and use thereof." This patent discloses an optically pure compound with a specific formula, along with its pharmaceutically acceptable salt and solvate. The patent also outlines the use of this compound in manufacturing medicaments and pharmaceutical compositions, showcasing its potential impact on healthcare.

Career Highlights

Yongle Chen is associated with Livzon Pharmaceutical Group Inc., a prominent company in the pharmaceutical industry. His role in the company allows him to contribute to innovative drug development and research. With a total of 1 patent, he has established himself as a valuable asset in the field.

Collaborations

Yongle Chen has worked alongside talented colleagues such as Jin Zhu and Qiwei Wang. Their collaborative efforts enhance the research and development processes within their organization.

Conclusion

Yongle Chen's contributions to pharmaceutical innovations highlight his dedication to improving medical treatments. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…